Acceleron Pharma, Inc. – Product Pipeline Review – 2016 :

“The Report Acceleron Pharma, Inc. – Product Pipeline Review – 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

Global Markets Directs, Acceleron Pharma, Inc. – Product Pipeline Review – 2016, provides an overview of the Acceleron Pharma, Inc.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Acceleron Pharma, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Download Sample copy of this Report at:


– The report provides a snapshot of the pipeline therapeutic landscape of Acceleron Pharma, Inc.

– The report provides overview of Acceleron Pharma, Inc. including its business description, key facts, and locations and subsidiaries

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report assesses Acceleron Pharma, Inc.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report features Acceleron Pharma, Inc.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

– Evaluate Acceleron Pharma, Inc.s strategic position with total access to detailed information on its product pipeline

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of therapeutics under development for Acceleron Pharma, Inc.

– Identify potential new clients or partners in the target demographic

– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding Acceleron Pharma, Inc.s pipeline depth and focus of pipeline therapeutics

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Follow us on LinkedIn:

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Acceleron Pharma, Inc. Snapshot 6

Acceleron Pharma, Inc. Overview 6

Key Information 6

Key Facts 6

Acceleron Pharma, Inc. – Research and Development Overview 7

Key Therapeutic Areas 7

Acceleron Pharma, Inc. – Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products – Monotherapy 11

Acceleron Pharma, Inc. – Pipeline Products Glance 12

Acceleron Pharma, Inc. – Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Acceleron Pharma, Inc. – Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Acceleron Pharma, Inc. – Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Acceleron Pharma, Inc. – Drug Profiles 16

luspatercept 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

dalantercept 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

sotatercept 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

ACE-083 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

ACE-1332 23

Product Description 23

Mechanism of Action 23

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074